In the non-obese diabetic (NOD) mouse model of type 1 diabetes mellitus (T1DM) development, TCDD activated AHR, increasing Foxp3+ T cells that exert anti-inflammatory effects against effector T cells, preventing T1DM development [124]. Here, FOXP3 is linked to type 1 diabetes mellitus.